<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Should hospitals be penalized for financial success?</title>
	<atom:link href="http://www.kevinmd.com/blog/2008/11/should-hospitals-be-penalized-for.html/feed" rel="self" type="application/rss+xml" />
	<link>http://www.kevinmd.com/blog/2008/11/should-hospitals-be-penalized-for.html</link>
	<description>medical blog</description>
	<lastBuildDate>Sun, 22 Nov 2009 14:15:05 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Anonymous</title>
		<link>http://www.kevinmd.com/blog/2008/11/should-hospitals-be-penalized-for.html/comment-page-1#comment-88247</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Thu, 20 Nov 2008 00:38:00 +0000</pubDate>
		<guid isPermaLink="false">http://clients.emmense.com/kevinmd/2008/11/should-hospitals-be-penalized-for-financial-success.html#comment-88247</guid>
		<description>Many interesting points have already been raised here, but I would like to expand the scope.  In line with the statement from above, &quot;Partners shouldn&#039;t be penalized for good fiscal sense and ruthless business strategy&quot;, could not the same be said about the vilified pharmaceutical industry.  Why is it so easy to see the virtue of success when it is a hospital system, but so difficult when it comes via the biopharmaceutical/device industries?  Maybe a rhetorical question right now, but some day I would like to hear some one provide an answer.&lt;br/&gt;&lt;br/&gt;Tom from Boston</description>
		<content:encoded><![CDATA[<p>Many interesting points have already been raised here, but I would like to expand the scope.  In line with the statement from above, &#8220;Partners shouldn&#8217;t be penalized for good fiscal sense and ruthless business strategy&#8221;, could not the same be said about the vilified pharmaceutical industry.  Why is it so easy to see the virtue of success when it is a hospital system, but so difficult when it comes via the biopharmaceutical/device industries?  Maybe a rhetorical question right now, but some day I would like to hear some one provide an answer.</p>
<p>Tom from Boston</p>
]]></content:encoded>
	</item>
</channel>
</rss>
